Brigatinib for treating ALK-positive non-small-cell lung cancer after crizotinib [ID1328]: A Single Technology Appraisal

Ed Griffin, Max Barnish, David Packman, Helen Coelho, Justin Matthews, Sophie Dodman, Sophie Robinson, Adam Dangoor, Nicole Dorey, Martin Hoyle

Research output: Book/ReportCommissioned reportResearch

LanguageEnglish
PublisherUniversity of Exeter
Commissioning bodyThe National Institute for Health and Care Excellence (NICE)
Number of pages189
Publication statusPublished - 2018
Externally publishedYes

Cite this

Griffin, E., Barnish, M., Packman, D., Coelho, H., Matthews, J., Dodman, S., ... Hoyle, M. (2018). Brigatinib for treating ALK-positive non-small-cell lung cancer after crizotinib [ID1328]: A Single Technology Appraisal. University of Exeter.
Griffin, Ed ; Barnish, Max ; Packman, David ; Coelho, Helen ; Matthews, Justin ; Dodman, Sophie ; Robinson, Sophie ; Dangoor, Adam ; Dorey, Nicole ; Hoyle, Martin. / Brigatinib for treating ALK-positive non-small-cell lung cancer after crizotinib [ID1328] : A Single Technology Appraisal. University of Exeter, 2018. 189 p.
@book{c31ec5f34a8d46cda69af13d562c53c7,
title = "Brigatinib for treating ALK-positive non-small-cell lung cancer after crizotinib [ID1328]: A Single Technology Appraisal",
author = "Ed Griffin and Max Barnish and David Packman and Helen Coelho and Justin Matthews and Sophie Dodman and Sophie Robinson and Adam Dangoor and Nicole Dorey and Martin Hoyle",
year = "2018",
language = "English",
publisher = "University of Exeter",

}

Griffin, E, Barnish, M, Packman, D, Coelho, H, Matthews, J, Dodman, S, Robinson, S, Dangoor, A, Dorey, N & Hoyle, M 2018, Brigatinib for treating ALK-positive non-small-cell lung cancer after crizotinib [ID1328]: A Single Technology Appraisal. University of Exeter.

Brigatinib for treating ALK-positive non-small-cell lung cancer after crizotinib [ID1328] : A Single Technology Appraisal. / Griffin, Ed; Barnish, Max; Packman, David; Coelho, Helen; Matthews, Justin; Dodman, Sophie; Robinson, Sophie; Dangoor, Adam; Dorey, Nicole; Hoyle, Martin.

University of Exeter, 2018. 189 p.

Research output: Book/ReportCommissioned reportResearch

TY - BOOK

T1 - Brigatinib for treating ALK-positive non-small-cell lung cancer after crizotinib [ID1328]

T2 - A Single Technology Appraisal

AU - Griffin, Ed

AU - Barnish, Max

AU - Packman, David

AU - Coelho, Helen

AU - Matthews, Justin

AU - Dodman, Sophie

AU - Robinson, Sophie

AU - Dangoor, Adam

AU - Dorey, Nicole

AU - Hoyle, Martin

PY - 2018

Y1 - 2018

M3 - Commissioned report

BT - Brigatinib for treating ALK-positive non-small-cell lung cancer after crizotinib [ID1328]

PB - University of Exeter

ER -

Griffin E, Barnish M, Packman D, Coelho H, Matthews J, Dodman S et al. Brigatinib for treating ALK-positive non-small-cell lung cancer after crizotinib [ID1328]: A Single Technology Appraisal. University of Exeter, 2018. 189 p.